PMID: 22576389May 12, 2012Paper

Incremental increases in glucocorticoid doses may reduce the risk of osmotic demyelination syndrome in a patient with hyponatremia due to central adrenal insufficiency

Internal Medicine
Katsunobu YoshiokaKeiko Yamagami

Abstract

A 50-year-old man was admitted to our hospital because of general malaise. Laboratory tests revealed severe hyponatremia (104 mEq/L), which was attributed to central adrenal insufficiency. To treat presumed central diabetes insipidus (CDI), we administered a small dose of hydrocortisone and gradually increased it to maintenance doses to prevent osmotic demyelination syndrome (ODS). Serum sodium levels did not increase more than 10 mEq/L/day and ODS did not occur. Thereafter, the patient was proven to have CDI. Incremental increases in glucocorticoid dose may reduce the risk of ODS for patients with hyponatremia due to central adrenal insufficiency, especially that complicated by CDI.

Citations

Oct 30, 2020·European Endocrinology·Aishwarya KrishnamurthyDeep Dutta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Related Papers

East African Medical Journal
M NgungaJ O Jowi
Annals of Neurology
A J BrantenR A Koene
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Yi JiangZu-Yuan Ren
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Duangpol SrimaneeKammant Phanthumchinda
© 2021 Meta ULC. All rights reserved